Rachael Natrajan
Citata da
Citata da
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with …
MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ...
European journal of cancer 47 (1), 8-32, 2011
Complex landscapes of somatic rearrangement in human breast cancer genomes
PJ Stephens, DJ McBride, ML Lin, I Varela, ED Pleasance, JT Simpson, ...
Nature 462 (7276), 1005-1010, 2009
Resistance to therapy caused by intragenic deletion in BRCA2
SL Edwards, R Brough, CJ Lord, R Natrajan, R Vatcheva, DA Levine, ...
Nature 451 (7182), 1111-1115, 2008
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells
G Molyneux, FC Geyer, FA Magnay, A McCarthy, H Kendrick, R Natrajan, ...
Cell stem cell 7 (3), 403-417, 2010
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer
N Turner, A Pearson, R Sharpe, M Lambros, F Geyer, MA Lopez-Garcia, ...
Cancer research 70 (5), 2085-2094, 2010
Breast cancer molecular profiling with single sample predictors: a retrospective analysis
B Weigelt, A Mackay, R A'hern, R Natrajan, DSP Tan, M Dowsett, ...
The lancet oncology 11 (4), 339-349, 2010
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ...
Breast Cancer Research 15 (5), 1-37, 2013
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
P Rathert, M Roth, T Neumann, F Muerdter, JS Roe, M Muhar, S Deswal, ...
Nature 525 (7570), 543-547, 2015
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
N Turner, MB Lambros, HM Horlings, A Pearson, R Sharpe, R Natrajan, ...
Oncogene 29 (14), 2013-2023, 2010
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
DR Robinson, S Kalyana-Sundaram, YM Wu, S Shankar, X Cao, B Ateeq, ...
Nature medicine 17 (12), 1646-1651, 2011
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
FC Geyer, M Lacroix-Triki, K Savage, M Arnedos, MB Lambros, A MacKay, ...
Modern pathology 24 (2), 209-231, 2011
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors
KJ Dedes, D Wetterskog, AM Mendes-Pereira, R Natrajan, MB Lambros, ...
Science translational medicine 2 (53), 53ra75-53ra75, 2010
Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma
MR Tanas, A Sboner, AM Oliveira, MR Erickson-Johnson, J Hespelt, ...
Science translational medicine 3 (98), 98ra82-98ra82, 2011
Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity
I Bajrami, JR Frankum, A Konde, RE Miller, FL Rehman, R Brough, ...
Cancer research 74 (1), 287-297, 2014
Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C
NH Dryden, LR Broome, F Dudbridge, N Johnson, N Orr, S Schoenfelder, ...
Genome research 24 (11), 1854-1868, 2014
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas
FC Geyer, B Weigelt, R Natrajan, MBK Lambros, D de Biase, R Vatcheva, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010
Tiling path genomic profiling of grade 3 invasive ductal breast cancers
R Natrajan, MB Lambros, SM Rodríguez-Pinilla, G Moreno-Bueno, ...
Clinical cancer research 15 (8), 2711-2722, 2009
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
R Natrajan, B Weigelt, A Mackay, FC Geyer, A Grigoriadis, DSP Tan, ...
Breast cancer research and treatment 121 (3), 575-589, 2010
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
E Arriola, C Marchio, DSP Tan, SC Drury, MB Lambros, R Natrajan, ...
Laboratory investigation 88 (5), 491-503, 2008
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer
KJ Dedes, R Natrajan, MB Lambros, FC Geyer, MA Lopez-Garcia, ...
European journal of cancer 47 (1), 138-150, 2011
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20